CLOs on the Move

C. R. Bard

www.crbard.com

 
C. R. Bard is a leading multinational developer, manufacturer, and marketer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology, and Surgical Specialties. Bard markets its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. Bard pioneered the development of single-patient-use medical products for hospital procedures; today Bard is dedicated to pursuing technological innovations that offer superior clinical benefits while helping to reduce overall health care costs.
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.crbard.com
  • 730 Central Ave
    New Providence, NJ USA 07974
  • Phone: 908.277.8000

Executives

Name Title Contact Details
Samrat Khichi
Senior Vice President - General Counsel - Secretary Profile
Candace Camarata
Assistant General Counsel - Litigation Profile
Anthony Colesanti
Assistant General Counsel at Davol - A Bard Company Profile
Ann Hurtado
General Counsel Profile
Adam Rappaport
Assistant General Counsel Profile

Similar Companies

Complete Medical Supplies

Complete Medical Supplies is a Suffern, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OXiGENE

OXiGENE is a biopharmaceutical company developing new and improved therapeutics that have the potential to deliver significant medical benefits to patients with cancer and serious medical conditions. Our primary focus is developing first-in-class anti-vascular drugs referred to as vascular disrupting agents (VDAs). Our lead compound in clinical development is fosbretabulin. VDAs are a new and highly differentiated class of anti-vascular drug that target existing tumor vasculature, leading to extensive tumor cell death. VDAs target the tumor vasculature rather than the tumor cells and therefore have broad potential therapeutic utility in cancer. Because VDAs act differently than anti-angiogenic drugs or cytotoxic chemotherapy drugs, VDAs are potentially complementary with anti-angiogenic drugs and chemotherapeutic agents. OXiGENE has ongoing VDA drug development programs and is committed to advancing the science of VDAs and their potential as innovative therapies to address unmet medical needs.

Brownfield Regional Medical Center

Brownfield Regional Medical Center is a Brownfield, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Criticare Systems

Founded in 1984, Criticare Systems, Inc. is an international medical device company headquartered in Waukesha, Wisconsin.

EUROIMMUN US

EUROIMMUN US is a Boonton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.